Cited by 3Advanced Drug Delivery SystemsAdvancements in Transdermal Drug DeliveryNanoparticle-Based Drug Delivery

Biomimetic nanomicelles: utilizing peptide transporters to overcome corneal barrier for treating fungal infection

Sathe, Priyadarshini, Nagarjuna, Vasagiri, Sharma, Hanuman, Velpandian, Thirumurthy, Garg, Prashant, Nirmal, Jayabalan·2025·Molecular Pharmaceutics

Abstract

The corneal barrier restricts the entry of xenobiotics (including drugs) in the anterior segment of the eye, resulting in less than 5% of the drug reaching the target site (deep corneal tissues) – necessitating frequent topical eye drop administration. Interestingly, despite these barriers, endogenous peptides are shuttled across the cornea by peptide transporters expressed on the corneal epithelium. The current study investigates the potential of targeting peptide transporters to increase the permeability of poorly permeable drugs across the cornea. D-α-tocopherol polyethylene glycol succinate (TPGS), an amphiphilic polymer, was conjugated with Glycyl-Sarcosine (Gly-Sar), a well-known peptide transporter ligand to develop nanomicelles. Natamycin, a poorly water-soluble and poorly permeable drug, was entrapped (0.6%) in Gly-Sar-TPGS-formulated nanomicelles. Both ex vivo and in vivo studies demonstrated that the natamycin-loaded Gly-Sar-TPGS nanomicelles (PeNatcel) enhanced permeation across the cornea. The PeNatcel demonstrated therapeutic efficiency against Candida albicans and Aspergillus flavus using in vitro and ex vivo antifungal studies. PeNatcel showed comparable activity against Candida albicans at 4 times a day dosing frequency compared to 12 times a day marketed 5% natamycin suspension. Consequently, the developed peptide transporter-specific ligand-conjugated nanomicelles delivery system can also be explored further for other water-insoluble and poorly permeable drugs.

Integrity signals

Registry

Crossref · 10.1021/acs.molpharmaceut.5c00423

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Gly-Sar-TPGS nanomicelles (PeNatcel) significantly enhanced corneal permeation and exhibited potent antifungal efficacy against Candida albicans and Aspergillus flavus.

    “When loaded with natamycin, the resulting Gly-Sar-TPGS nanomicelles (PeNatcel) significantly enhanced corneal permeation and exhibited potent antifungal efficacy against Candida albicans and Aspergillus flavus.”
  • PeNatcel achieved comparable therapeutic activity with only 4 daily administrations, in contrast to the 12 doses required by a commercial 5% natamycin suspension.

    “Importantly, PeNatcel achieved comparable therapeutic activity with only 4 daily administrations, in contrast to the 12 doses required by a commercial 5 % natamycin suspension [142].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sathe, P., Nagarjuna, V., Sharma, H., Velpandian, T., Garg, P., & Nirmal, J.
Affiliations
  • Birla Institute of Technology and Science - Hyderabad Campus (IN)
  • L V Prasad Eye Institute (IN)
  • All India Institute of Medical Sciences (IN)
Corresponding author
Nirmal, Jayabalan
Venue
Molecular Pharmaceutics
Published
2025-10-20
Volume
22
Issue
11
Pages
6575-6587
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W4415368501
Cited by
3
References
64
Citations by year
2026: 2 · 2025: 1
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
Indian Council of Medical Research (5/3/8/21/ITR-F/2020-ITR)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
peptide transporters, corneal permeation, nanomicelles, TPGS, natamycin, antifungal drug delivery, Candida albicans, Aspergillus flavus, corneal epithelium, poorly water-soluble drugs, corneal barrier, topical ocular drug delivery
MeSH terms
Animals, Antifungal Agents, Aspergillus flavus, Candida albicans, Cornea, Humans, Micelles, Peptides, Permeability, Natamycin, Rabbits, Vitamin E, Drug Delivery Systems, Epithelium, Corneal, Biomimetics, Biomimetic Materials, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review